Literature DB >> 16133548

Genetic polymorphisms and linkage disequilibrium of sulfotransferase SULT1A1 and SULT1A2 in a Korean population: comparison of other ethnic groups.

Kyoung-Ah Kim1, Sook-Young Lee, Pil-Whan Park, Jong-Myung Ha, Ji-Young Park.   

Abstract

AIMS: To determine the allele frequencies of sulfotransferases (SULTs) 1A1 and 1A2 and their linkage disequilibrium in a Korean population and compare them with those of other ethnic groups.
METHODS: Genotypes of the SULT1A1*1, *2, and *3 and SULT1A2*1, *2, and *3 allelic variants were determined in 234 Korean subjects using polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) methods.
RESULTS: Allele frequencies for SULT1A1*1 and *2 were 0.876 [95% confidence interval (CI), 0.843-0.905] and 0.124 (95% CI, 0.096-0.157), respectively. Similarly, those for SULT1A2*1 and *2 were 0.885 (95% CI, 0.852-0.912) and 0.115 (95% CI, 0.088-0.150), respectively. However, no subject with SULT1A1*3 or SULT1A2*3 was detected. These genotype distributions are similar to those of Asian populations including the Chinese and Japanese, but quite different from other ethnic groups such as African-Americans and Caucasians. The expected allelic frequencies of SULT1A1 and SULT1A2 at Hardy-Weinberg equilibrium are quite similar to the observed distributions in the population. SULT1A1*2 and SULT1A2*2, the most common variant alleles of these two genes, are strongly and positively linked in the Korean population (D' = 0.8919, chi2 = 343.24, P = 0.0034).
CONCLUSIONS: SULT1A1*2 and SULT1A2*2 are the major allelic variants in the Korean population, whereas the SULT1A1*3 and SULT1A2*3 alleles were not found. SULT1A1*2 and SULT1A2*2 are strongly linked.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16133548     DOI: 10.1007/s00228-005-0989-3

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  27 in total

1.  The relationship among the polymorphisms of SULT1A1, 1A2 and different types of cancers in Taiwanese.

Authors:  Ching-Tien Peng; Jui-Chang Chen; Kun-Tu Yeh; Yu-Feng Wang; Ming-Feng Hou; Tai-Ping Lee; Mu-Chih Shih; Jan-Yi Chang; Jan-Gowth Chang
Journal:  Int J Mol Med       Date:  2003-01       Impact factor: 4.101

2.  cDNA cloning and expression of a new form of human aryl sulfotransferase.

Authors:  X Zhu; M E Veronese; P Iocco; M E McManus
Journal:  Int J Biochem Cell Biol       Date:  1996-05       Impact factor: 5.085

Review 3.  Polymorphisms in drug-metabolizing enzymes: what is their clinical relevance and why do they exist?

Authors:  D W Nebert
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

4.  Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy.

Authors:  Susan Nowell; Carol Sweeney; Maria Winters; Angie Stone; Nicholas P Lang; Laura F Hutchins; Fred F Kadlubar; Christine B Ambrosone
Journal:  J Natl Cancer Inst       Date:  2002-11-06       Impact factor: 13.506

5.  Primary structures and properties of two related forms of aryl sulfotransferases in human liver.

Authors:  S Ozawa; K Nagata; M Shimada; M Ueda; T Tsuzuki; Y Yamazoe; R Kato
Journal:  Pharmacogenetics       Date:  1995

6.  Molecular characterisation of a human aryl sulfotransferase cDNA.

Authors:  X Zhu; M E Veronese; L N Sansom; M E McManus
Journal:  Biochem Biophys Res Commun       Date:  1993-04-30       Impact factor: 3.575

7.  A novel polylocus method for linkage analysis using the lod-score or affected sib-pair method.

Authors:  J D Terwilliger; J Ott
Journal:  Genet Epidemiol       Date:  1993       Impact factor: 2.135

8.  Localization and characterization of phenol sulfotransferase in human platelets.

Authors:  R F Hart; K J Renskers; E B Nelson; J A Roth
Journal:  Life Sci       Date:  1979-01-08       Impact factor: 5.037

9.  Phenotype-genotype relationships of SULT1A1 in human liver and variations in the IC50 of the SULT1A1 inhibitor quercetin.

Authors:  A M Rossi; V Maggini; E Fredianelli; D Di Bello; A Pietrabissa; F Mosca; R Barale; G M Pacifici
Journal:  Int J Clin Pharmacol Ther       Date:  2004-10       Impact factor: 1.366

Review 10.  Human dehydroepiandrosterone sulfotransferase: molecular cloning of cDNA and genomic DNA.

Authors:  D M Otterness; R Weinshilboum
Journal:  Chem Biol Interact       Date:  1994-06       Impact factor: 5.192

View more
  5 in total

1.  Sulfotransferase 1A1 Arg(213)His polymorphism and prostate cancer risk.

Authors:  Serdal Arslan; Yavuz Silig; Hatice Pinarbasi
Journal:  Exp Ther Med       Date:  2011-08-12       Impact factor: 2.447

2.  Association of sulfotransferase SULT1A1 with breast cancer risk: a meta-analysis of case-control studies with subgroups of ethnic and menopausal statue.

Authors:  Yiwei Jiang; Liheng Zhou; Tingting Yan; Zhenzhou Shen; Zhimin Shao; Jinsong Lu
Journal:  J Exp Clin Cancer Res       Date:  2010-07-21

3.  Sulfotransferase 1A1 (SULT1A1) polymorphism and susceptibility to primary brain tumors.

Authors:  F Bardakci; S Arslan; S Bardakci; A O Binatli; M Budak
Journal:  J Cancer Res Clin Oncol       Date:  2007-06-29       Impact factor: 4.322

4.  Relationship between genotypes Sult1a2 and Cyp2d6 and tamoxifen metabolism in breast cancer patients.

Authors:  Ana Fernández-Santander; María Gaibar; Apolonia Novillo; Alicia Romero-Lorca; Margarita Rubio; Luis Miguel Chicharro; Armando Tejerina; Fernando Bandrés
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

5.  Genetic Polymorphisms of Very Important Pharmacogene Variants in the Blang Population from Yunnan Province in China.

Authors:  Yuliang Wang; Linna Peng; Hongyan Lu; Zhanhao Zhang; Shishi Xing; Dandan Li; Chunjuan He; Tianbo Jin; Li Wang
Journal:  Pharmgenomics Pers Med       Date:  2021-12-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.